AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON JANUARY 22, 2001
                                                    REGISTRATION NO. ___________
================================================================================

                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549
                                ----------------

                                    FORM SB-2
                             REGISTRATION STATEMENT
                                      UNDER
                           THE SECURITIES ACT OF 1933
                                ----------------
                                WEBNUTRI.COM INC.
              (EXACT NAME OF SMALL BUSINESS ISSUER IN ITS CHARTER)

           WASHINGTON                      5499                91-2086638
 (STATE OR OTHER JURISDICTION OF     (PRIMARY STANDARD      (I.R.S. EMPLOYER
  INCORPORATION OR ORGANIZATION)      INDUSTRIAL CODE)    IDENTIFICATION NUMBER)

                             5621 EAGLE HARBOUR ROAD
                 WEST VANCOUVER, BRITISH COLUMBIA CANADA V7W 1P4
                                 (604) 922-4068
          (ADDRESS AND TELEPHONE NUMBER OF PRINCIPAL EXECUTIVE OFFICES)
                                ----------------

            AGENT FOR SERVICE:                            WITH A COPY TO:
          PETER FINCK, PRESIDENT                         JAMES L. VANDEBERG
             WEBNUTRI.COM INC.                       OGDEN MURPHY WALLACE, PLLC
         5621 EAGLE HARBOUR ROAD                   1601 FIFTH AVENUE, SUITE 2100
WEST VANCOUVER, BRITISH COLUMBIA CANADA V7W 1P4      SEATTLE, WASHINGTON 98101
             (604) 922-4068                              (206) 447-7000
  (NAME, ADDRESS, INCLUDING ZIP CODE, AND TELEPHONE NUMBER, INCLUDING AREA CODE,
                              OF AGENT FOR SERVICE)

        APPROXIMATE DATE OF COMMENCEMENT OF PROPOSED SALE TO THE PUBLIC:
 As soon as practicable after the effective date of this Registration Statement.

     If any of the securities being registered on this form are to be offered on
a  delayed  or  continuous  basis pursuant to Rule 415 under the Securities Act,
check  the  following  box. [X]

     If  this  Form  is  filed to register additional securities for an offering
pursuant  to  Rule  462(b) under the Securities Act, check the following box and
list  the  Securities Act registration statement number of the earlier effective
registration  statement  for  the  same  offering. [_]

     If  this  Form  is a post-effective amendment filed pursuant to Rule 462(c)
under  the  Securities  Act, check the following box and list the Securities Act
registration  statement  number  of the earlier effective registration statement
for  the  same  offering. [_]

     If  this  Form  is a post-effective amendment filed pursuant to Rule 462(d)
under  the  Securities  Act, check the following box and list the Securities Act
registration  statement  number  of the earlier effective registration statement
for  the  same  offering. [_]

     If  delivery of the prospectus is expected to be made pursuant to Rule 434,
check  the  following  box. [_]



                         CALCULATION OF REGISTRATION FEE

=========================================================================================
                                            PROPOSED        PROPOSED
                               AMOUNT       MAXIMUM          MAXIMUM
 TITLE OF EACH CLASS OF        TO BE     OFFERING PRICE     AGGREGATE       AMOUNT OF
SECURITIES TO BE REGISTERED  REGISTERED     PER UNIT     OFFERING PRICE  REGISTRATION FEE
- ---------------------------  ----------  --------------  --------------  ---------------
                                                             
Class A Common Stock . . .    2,500,000  $          .01  $       25,000              6.25
=========================================================================================


     THE  REGISTRATION HEREBY AMENDS THIS REGISTRATION STATEMENT ON SUCH DATE OR
DATES AS MAY BE NECESSARY TO DELAY ITS EFFECTIVE DATE UNTIL THE REGISTRANT SHALL
FILE  A  FURTHER  AMENDMENT  WHICH  SPECIFICALLY  STATES  THAT THIS REGISTRATION
STATEMENT  SHALL  THEREAFTER BECOME EFFECTIVE IN ACCORDANCE WITH SECTION 8(A) OF
THE  SECURITIES  ACT  OF  1933  OR UNTIL THE REGISTRATION STATEMENT SHALL BECOME
EFFECTIVE  ON SUCH DATE AS THE COMMISSION, ACTING PURSUANT TO SAID SECTION 8(A),
MAY  DETERMINE.



                    SUBJECT TO COMPLETION-[ENTER DATE, 2001]

PROSPECTUS

                                       , 2001



                                WEBNUTRI.COM INC.

                             5621 EAGLE HARBOUR ROAD
                        WEST VANCOUVER, BC CANADA V7W 1P4
                                 (604) 922-4068




                        2,500,000 SHARES OF COMMON STOCK




     This  is  the initial public offering of common stock of WebNutri.com Inc.,
and no public market currently exists for shares of WebNutri's common stock. The
initial  public  offering  price  is  $0.01  per share of common stock which was
arbitrarily  determined.  The  offering  is  on a best efforts-no minimum basis.
There is no minimum purchase requirement and no arrangement to place funds in an
escrow,  trust, or similar account.  The latest date on which this offering will
close  will  be  90  days  after  the  date  of  this  prospectus.




                               ----------------


                 THIS INVESTMENT INVOLVES A HIGH DEGREE OF RISK.
                     SEE "RISK FACTORS" BEGINNING ON PAGE 2.


                               ----------------




     NEITHER  THE  SECURITIES  AND  EXCHANGE COMMISSION NOR ANY STATE SECURITIES
COMMISSION  HAS  APPROVED  OR DISAPPROVED OF THESE SECURITIES OR PASSED UPON THE
ADEQUACY OR ACCURACY OF THIS PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY IS A
CRIMINAL  OFFENSE.

WE  WILL  AMEND AND COMPLETE THE INFORMATION IN THIS PROSPECTUS. THE INFORMATION
IN  THIS  PROSPECTUS  IS  NOT COMPLETE AND MAY BE CHANGED. WE MAY NOT SELL THESE
SECURITIES  UNTIL  THE  REGISTRATION  STATEMENT  FILED  WITH  THE SECURITIES AND
EXCHANGE  COMMISSION IS EFFECTIVE. THIS PROSPECTUS IS NOT AN OFFER TO SELL THESE
SECURITIES  AND  IT  IS  NOT  SOLICITING AN OFFER TO BUY THESE SECURITIES IN ANY
STATE  WHERE  THE  OFFER  OR  SALE  IS  NOT  PERMITTED.





                                      TABLE OF CONTENTS


                                                                                        PAGE
                                                                                        ----
                                      PART I-PROSPECTUS
                                                                                     
Prospectus Summary  .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .     1

Risk Factors  .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .     2

Use of Proceeds  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .     3

Determination of Offering Price  . . . . . . . . . . . . . . . . . . . . . . . . . . .     3

Selling Security Holders  .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .     3

Plan of Distribution  .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .     3

Legal Proceedings  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .     4

Directors, Executive Officers, Promoters and Control Persons  .. . . . . . . . . . . .     4

Security Ownership of Certain Beneficial Owners and Management  .. . . . . . . . . . .     4

Description of Securities  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .     5

Interest of Named Experts and Counsel  . . . . . . . . . . . . . . . . . . . . . . . .     5

Disclosure of Commission Position on Indemnification for Securities Act Liabilities  .     5

Description of Business  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .     6

Management's Discussion and Analysis or Plan of Operation  . . . . . . . . . . . . . .    13

Description of Property  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .    14

Certain Relationships and Related Transactions  .. . . . . . . . . . . . . . . . . . .    14

Market for Common Equity and Related Stockholder Matters  .. . . . . . . . . . . . . .    14

Executive Compensation  .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .    15

Changes In and Disagreements with Accountants on Accounting and
  Financial Disclosure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .    15

Financial Statements  .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .   F-1




                               PROSPECTUS SUMMARY

WEBNUTRI.COMINC.

     WebNutri.com  Inc.  is  a corporation formed under the laws of the State of
Washington,  whose  principal  executive  offices are located in West Vancouver,
British  Columbia,  Canada.

     The  primary  objective of the business is designed to market high-quality,
low-cost  vitamins,  minerals,  nutritional  supplements,  and  other health and
fitness  products  to  medical  professionals, alternative health professionals,
martial  arts  studios  and instructors, sports and fitness trainers, health and
fitness  professionals, school and other fund raising programs and other similar
types  of  customers  via  the  Internet  for sale to their clients in Michigan.


NAME,  ADDRESS,  AND  TELEPHONE  NUMBER  OF  REGISTRANT

     WebNutri.com  Inc.
     5621  Eagle  Harbour  Road
     West  Vancouver,  British  Columbia  Canada
     (604)  922-4068


THE  OFFERING



                                                                                       
  Price per share Offered   . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 0.01
  Common Stock Offered by WebNutri  .  . . . . . . . . . . . . . . . . . . . . . . . . .  2,500,000 shares
  Common Stock Outstanding Prior to Offering  . . . . . . . . . . . . . . . . . . . . .   5,100,000 shares
  Common Stock Outstanding After Offering Assuming 50% of the Offering is Sold  . . . .   6,350,000 shares
  Common Stock Outstanding After Offering Assuming 100% of the Offering is Sold . . . .   7,600,000 shares




     WebNutri expects to use the net proceeds for organizational purposes and to
determine  the  feasibility  of selling Vitamineralherb.com products to specific
markets.


                                        1

                                  RISK FACTORS

     WebNutri.com Inc.Has  Incurred Losses Since Its Inception December 15, 2000
     And Expects  Losses  to  Continue  For  the  Foreseeable  Future

     WebNutri  is  in  the  extreme  early  stages of development and could fail
before  implementing  its  business  plan.  It is a "start up" venture that will
incur net losses for the foreseeable future. WebNutri has only recently acquired
its  principal  asset.  WebNutri  will incur additional expenses before becoming
profitable, if it ever becomes profitable. It is a relatively young company that
has no history of earnings or profit. There is no assurance that it will operate
profitably  in  the  future  or  provide  a  return on investment in the future.

     Changes  or  Interruptions to WebNutri's Arrangements with Its Supplier May
     Have an  Adverse  Effect  on  Its  Ability  to  Operate

     If WebNutri's  licensor  defaults  under its  agreement  with its supplier,
WebNutri  could  lose  access  to  its   manufacturing   source,   and  WebNutri
distribution rights would become meaningless. Similarly, any dispute between the
supplier and licensor could prevent WebNutri from selling or delivering  product
to its customers. Any termination or impairment of WebNutri's license rights and
access to products could prevent  WebNutri from  implementing its business plan,
thereby limiting its profitability and decreasing the value of its stock.

     If  the  Vitamineralherb.com  Business  Plan Does Not Prove To Be Feasible,
     WebNutri May  Be  Considered  a  Blank  Check  Company Which Would Restrict
     Resales of Its Stock

     If  the Vitamineralherb.com business plan does not prove to be economically
feasible,  and  WebNutri  does  not  otherwise  have a specific business plan or
purpose, WebNutri would be considered a "blank check company", which could limit
an  investor's  ability  to  sell its stock, thereby decreasing the value of the
stock.  A  "blank  check  company" is subject to Rule 419 of the Securities Act.
Pursuant  to  Rule  419, all funds raised by and securities issued in connection
with  a public offering by a blank check company must be held in escrow, and any
such  securities may not be transferred. Many states have also enacted statutes,
rules  and  regulations limiting the sale of securities of blank check companies
within  their  respective  jurisdictions. As a result, WebNutri would have great
difficulty  raising  additional  capital.  In addition, there would be a limited
public  market, if any, for resale of the shares of WebNutri common stock issued
in  this  offering.

     WebNutri May Need Additional Financing Which May Not Be Available, or Which
     May Dilute  the  Ownership  Interests  of  Investors

     WebNutri's  ultimate success will depend on its ability to raise additional
capital. No commitments to provide additional funds have been made by management
or other shareholders. WebNutri has not investigated the availability, source or
terms  that  might  govern the acquisition of additional financing. WebNutri may
raise  additional  funds  through  the  issuance  of  equity,  equity-related or
convertible  debt  securities.  The  issuance  of  additional  common stock will
dilute  existing  stockholders.  WebNutri  may  issue  securities  with  rights,
preferences  or privileges senior to those of the rights of its common stock and
its stockholders may experience additional dilution.  When additional capital is
needed,  there  is no assurance that funds will be available from any source or,
if  available, that they can be obtained on terms acceptable to WebNutri. If not
available,  WebNutri's  operations  would  be  severely limited, and it would be
unable  to  implement  its  business  plan.

     Purchasers  Must  Rely  on  Mr.  Finck's  Abilities For All Decisions As He
     Will Control the Majority of the Stock After the Offering. WebNutri Has  No
     Employment Agreement  With  Mr.  Finck  and  He  Spends Only  Part-time  On
     Its  Business. His Leaving  May  Adversely  Effect  WebNutri's  Ability  To
     Operate

     Mr. Finck is serving as WebNutri's sole officer and director. WebNutri will
be  heavily  dependent upon Mr. Finck's entrepreneurial skills and experience to
implement  its business plan and may, from time to time, find that her inability
to  devote  full  time  and  attention to its affairs will result in delay(s) in
progress  towards  the  implementation  of  its business plan or in a failure to
implement  its  business  plan.  Moreover,  WebNutri does not have an employment
agreement  with  Mr.  Finckand  as a result, there is no assurance that she will
continue  to  manage  its affairs in the future. Nor has WebNutri obtained a key
man  life insurance policy on Mr. Finck. WebNutri could lose the services of Mr.
Finck,  or  Mr.  Finck  could  decide  to join a competitor or otherwise compete
directly  or  indirectly  with  WebNutri, which would have a significant adverse
effect  on  its business and could cause the price of its stock to be worthless.
The  services  of  Mr.  Finck  would  be  difficult  to  replace.


                                        2

                SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

     Some  of  the  statements  under  "Prospectus  Summary",   "Risk  Factors",
"Management's  Discussion  and  Analysis of Financial  Condition  and Results of
Operations",  "Description  of  Business",  and  elsewhere  in  this  prospectus
constitute   forward-looking   statements.  In  some  cases,  you  can  identify
forward-looking  statements  by  terminology  such as "may",  "will",  "should",
"expects",  "plans",   "anticipates",   "believes",   "estimated",   "predicts",
"potential",  or  "continue"  or the negative of such terms or other  comparable
terminology. These statements are only predictions and involve known and unknown
risks,  uncertainties,  and  other  factors  that may  cause  WebNutri's  actual
results,  levels of activity,  performance,  or  achievements  to be  materially
different  from  any  future  results,  levels  of  activity,   performance,  or
achievements  expressed  or implied by such  forward-looking  statements.  These
factors  include,  among other  things,  those listed  under "Risk  Factors" and
elsewhere in this prospectus.  Although  WebNutri believes that the expectations
reflected in the forward-looking  statements are reasonable, it cannot guarantee
future results, levels of activity, performance, or achievements.


                                 USE OF PROCEEDS

     The  net  proceeds  to  WebNutri  from  the sale of the 2,500,000 shares of
common  stock  offered  by WebNutri hereby at an assumed initial public offering
price of $.01 per share are estimated to be $25,000. WebNutri expects to use the
net  proceeds  as  follows:



                                                     ASSUMING SALE OF    ASSUMING SALE OF
                                                    50% OF STOCK BEING  100% OF STOCK BEING
     PURPOSE                                             OFFERED             OFFERED
     -------                                        ------------------  -------------------
                                                                  
     Organizational Purposes  . . . . . . . . . .   $            1,000  $             1,000
     Feasibility of License/Market Research . . .   $           11,500  $            13,500
     Operational Expenses . . . . . . . . . . . .   $                0  $            10,500



     WebNutri  continually  evaluates  other  business opportunities that may be
available  to  it,  whether  in  the  form  of  assets  acquisitions or business
combinations.  WebNutri  may  use  a portion of the proceeds for these purposes.
WebNutri  is  not  currently  a  party  to  any  contracts,  letters  of intent,
commitments  or  agreements  and is not currently engaged in active negotiations
with  respect  to  any  acquisitions.

     WebNutri  has not yet  determined  the  amount of net  proceeds  to be used
specifically  for  any  of  the  foregoing  purposes.  Accordingly,   WebNutri's
management will have significant flexibility in applying the net proceeds of the
offering.


                         DETERMINATION OF OFFERING PRICE

     WebNutri  arbitrarily  determined  the price of the stock in this Offering.
The  offering  price  is  not  an indication of and is not based upon the actual
value  of  WebNutri.  It  bears  no  relationship  to  the book value, assets or
earnings  of  WebNutri  or  any other recognized criteria of value. The offering
price  should  not be regarded as an indicator of the future market price of the
securities.


                            SELLING SECURITY HOLDERS

     There  are  no  selling  security  holders.


                              PLAN OF DISTRIBUTION

     WebNutri  will offer and sell its common stock through its sole officer and
director,  Peter  Finck,  pursuant  to  and in compliance with Rule 3a4-1 of the
Exchange  Act.  All sales will be made in compliance with the securities laws of
local  jurisdictions.


                                        3

                                LEGAL PROCEEDINGS

     WebNutri  is  not a party to any pending legal proceeding or litigation and
none  of its property is the subject of a pending legal proceeding. Further, the
officer  and  director  knows  of  no  legal proceedings against WebNutri or its
property  contemplated  by  any  governmental  authority.


          DIRECTORS, EXECUTIVE OFFICERS, PROMOTERS AND CONTROL PERSONS

     The  following table sets forth the name, age and position of each director
and  executive  officer  of  WebNutri:

       NAME                    AGE    POSITION
       ----                    ---    --------
       Peter Finck  . . . . .   41    President, Secretary, Treasurer, Director

     In  December,  2000, Mr. Finck was elected as the sole officer and director
of  WebNutri.  He  will  serve  until  the  first  annual  meeting of WebNutri's
shareholders and his successors are elected and qualified. Thereafter, directors
will be elected for one-year terms at the annual shareholders' meeting. Officers
will  hold their positions at the pleasure of the board of directors, absent any
employment  agreement.

     In 1998,  Peter  Finck  helped form a  consulting  and  corporate  training
company  called Rock The Boat Ventures in the Art of  Collaborative  Performance
Inc. The company's primary purpose is to provide consulting,  training workshops
and training licences to individuals, organizations and companies. To date, Rock
The Boat has facilitated contracts with several organizations  including a large
British Colombian  government Health Region and Seattle Pacific University.  Mr.
Finck is a director of Rock The Boat and is active in the  administration of and
the ongoing presentations. Rock the Boat has active contracts with clients.

     In 1995, Mr. Finck  incorporated as Peter Finck Inc. The company's  primary
business is to provide  residential  and consulting  services to the Province of
British  Columbia.  In 1997,  Mr.  Finck  changed  the name of the  company to A
Community Vision For Children And Families Ltd.  (Community  Vision Mr. Finck is
currently the executive director and sole director of Community.

     Prior  to his work with Community Vision, Mr. Finck held several front-line
positions  with  Pacific  Legal Education Association from May 1984 to September
1994.  While  employed  with  this  organization, Mr. Finck's positions included
Family  Support  Worker,  Activity  Supervisor Team Leader, Contract Manager, as
well  as  an  executive  management  post  as  Acting  Agency  Director.

     In December 2000, Mr. Finck became president of Fraser Valley Education and
Therapy  Services  Inc.,  a  privately held corporation, of which he is majority
shareholder.


         SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

     The  following  table  sets  forth,  as  of  December  31, 2000, WebNutri's
outstanding  common  stock  owned  of  record  or beneficially by each Executive
Officer  and  Director  and  by each person who owned of record, or was known by
WebNutri  to  own  beneficially,  more  than  5%  of  its  common stock, and the
shareholdings  of  all  Executive Officers and Directors as a group. Each person
has  sole  voting  and  investment  power  with  respect  to  the  shares shown.


                                                     SHARES    PERCENTAGE OF
 NAME                                                 OWNED     SHARES OWNED
 ----                                               ---------  -------------
 Michael Kirsh . . . . . . . . . . . . . . . . . .  5,100,000           100%
    5076 Angus Drive
    Vancouver, British Columbia Canada V6M 3M5
 All Executive Officers and Directors as a Group
    (1 Individual). . . . . . . . . . . . . . . . .         0             0%


                                        4

                            DESCRIPTION OF SECURITIES

     The  following  description of WebNutri's capital stock is a summary of the
material terms of its capital stock. This summary is subject to and qualified in
its  entirety  by  WebNutri's  articles  of incorporation and bylaws, and by the
applicable  provisions  of  Washington  law.

     The  authorized  capital  stock of WebNutri consists of 120,000,000 shares:
100,000,000  shares  of Common Stock having a par value of $0.0001 per share and
20,000,000  shares  of  Preferred  Stock.  The  articles of incorporation do not
permit  cumulative voting for the election of directors, and shareholders do not
have  any  preemptive  rights  to  purchase  shares  in  any  future issuance of
WebNutri's  common  stock.

     The  holders  of  shares of common stock of WebNutri do not have cumulative
voting  rights  in connection with the election of the Board of Directors, which
means  that  the holders of more than 50% of such outstanding shares, voting for
the election of directors, can elect all of the directors to be elected, if they
so  choose,  and, in such event, the holders of the remaining shares will not be
able  to  elect  any  of  WebNutri's  directors.

     The  holders  of  shares  of common stock are entitled to dividends, out of
funds  legally  available  therefor,  when  and  as  declared  by  the  Board of
Directors.  The  Board  of  Directors has never declared a dividend and does not
anticipate  declaring a dividend in the future. Each outstanding share of common
stock  entitles  the  holder  thereof  to one vote per share on all matters. The
holders of the shares of common stock have no preemptive or subscription rights.
In  the  event  of  liquidation,  dissolution  or  winding  up of the affairs of
WebNutri,  holders  are entitled to receive, ratably, the net assets of WebNutri
available  to  shareholders  after  payment  of  all  creditors.

     All  of  the  issued  and  outstanding  shares  of  common  stock  are duly
authorized,  validly  issued, fully paid, and non-assessable. To the extent that
additional  shares of WebNutri's common stock are issued, the relative interests
of  existing  shareholders  may  be  diluted.


                      INTEREST OF NAMED EXPERTS AND COUNSEL

Neither  Manning  Elliott  nor  Ogden  Murphy  Wallace,  PLLC  was employed on a
contingent  basis  in connection with the registration or offering of WebNutri's
common  stock.


                      DISCLOSURE OF COMMISSION POSITION ON
                 INDEMNIFICATION FOR SECURITIES ACT LIABILITIES

     WebNutri's  articles  of  incorporation  provide that it will indemnify its
officers  and  directors  to  the full extent permitted by Washington state law.
WebNutri's  bylaws  provide that it will indemnify and hold harmless each person
who  was,  is or is threatened to be made a party to or is otherwise involved in
any  threatened  proceedings  by  reason  of the fact that he or she is or was a
director  or officer of WebNutri or is or was serving at the request of WebNutri
as  a director, officer, partner, trustee, employee, or agent of another entity,
against  all  losses,  claims,  damages,  liabilities  and expenses actually and
reasonably  incurred  or  suffered  in  connection  with  such  proceeding.

     Insofar as indemnification for liabilities arising under the Securities Act
of  1933  may  be  permitted  to  directors, officers and controlling persons of
WebNutri  pursuant  to  the  forgoing provisions or otherwise, WebNutri has been
advised  that,  in  the  opinion of the Securities and Exchange Commission, such
indemnification  is  against  public  policy  as  expressed  in that Act and is,
therefore,  unenforceable.


                                        5

                             DESCRIPTION OF BUSINESS

     General

     WebNutri  was  incorporated  under  the  laws of the State of Washington on
December  15, 2000, and is in its early developmental and promotional stages. To
date, WebNutri's only activities have been organizational, directed at acquiring
its  principal  asset,  raising  its initial capital and developing its business
plan.  WebNutri  has  not  commenced commercial operations. WebNutri has no full
time  employees  and  owns  no  real  estate.


     Acquisition  of  The  License

     On December 15, 2000, WebNutri's sole shareholder, Michael Kirsh, in return
for  3,500,000  shares  of  WebNutri's common stock, transferred to WebNutri his
rights  under  that  certain  License  Agreement  with Vitamineralherb.com.  The
License  Agreement  grants  an exclusive right to distribute Vitamineralherb.com
products  to  health  and fitness professionals in Alabama and Louisiana via the
Internet.  Mr.  Kirsh acquired the license from Vitamineralherb.com for $35,000.


     The  License

     WebNutri  has a three year license to market and sell  vitamins,  minerals,
nutritional  supplements,  and other  health  and  fitness  products  to medical
professionals,  alternative  health  professionals,  martial  arts  studios  and
instructors,   sports  and   fitness   trainers,   other   health  and   fitness
professionals, school and other fund raising programs and other similar types of
customers via the Internet for sale to their  clients.  WebNutri's  territory is
Alabama and Louisiana. The license will be automatically renewed unless WebNutri
or Vitamineralherb.com gives the other notice of its intent not to renew.

     Vitamineralherb.com  has agreed to provide certain business  administrative
services to WebNutri,  including product development,  store inventory,  website
creation and maintenance, establishment of banking liaisons, and development and
maintenance of an order fulfillment  system,  thereby enabling WebNutri to focus
strictly on marketing  and sales.  Some  services,  such as  development  of the
website   and   the   order   fulfillment    system,   will   be   provided   by
Vitamineralherb.com,  while  others,  such  as  product  development  and  store
inventory,  will be provided by the product supplier.  Vitamineralherb.com  sets
the price for products based on the  manufacturer's  price, plus a mark up which
Vitamineralherb.com and WebNutri share equally.

     WebNutri  and its  customers  will also be able to  request  quotes for and
order  custom-formulated  and  custom-labeled  products via the  website.  Three
different  labeling options are available to customers:  First,  products may be
ordered with the  manufacturer's  standard label with no customization.  Second,
the fitness or health  professional may customize the labels by adding its name,
address,  and phone number to the standard  label.  In most cases,  these labels
would be a standardized label with product  information and a place on the label
for  the  wording   "Distributed  by."  This  gives  these  health  and  fitness
professionals a competitive edge. Third, labels may be completely customized for
the health or fitness professional.

     When  a  fitness  or  health  professional  becomes  a  client,  WebNutri's
salesperson  will show the client how to access the Vitamineralherb.com website.
The client is assigned an identification number that identifies it by territory,
salesperson,  and  business  name, address, and other pertinent information. The
health  or  fitness professional may then order the products it desires directly
through  the  Vitamineralherb.com  website.  It is anticipated that the customer
will  pay  for the purchase with a credit card, electronic check ("e-check"), or
debit  card.  All  products  will be shipped by the manufacturer directly to the
professional  or  its  clients.

     The website is maintained by Vitamineralherb.com, and each licensee pays an
annual website  maintenance fee of $500. All financial  transactions are handled
by   Vitamineralherb.com's   Internet  clearing  bank.  The  Vitamineralherb.com
webmaster downloads e-mail orders several times a day, checks with clearing bank
for payment and then submits the product  order and  electronic  payment to Ives
Formulation  Co.  Vitamineralherb.com  then  forwards the money due WebNutri via
electronic  funds  transfer.  Vitamineralherb.com's  software  tracks  all sales
through  the  customer's  identification  number,  and at month end,  e-mails to
WebNutri  and  customer  a  detailed   report   including   sales   commissions.
Vitamineralherb.com  has indicated that it will use e-commerce  advertising such
as banner ads on major  servers and  websites,  as well as trying to insure that
all major search engines pick Vitamineralherb.com  first. Sales originating from
the website to customers located in Alabama and Louisiana will  automatically be
assigned to WebNutri.


                                        6

     Background  on  the  Manufacturer  and  Distributor

     Vitamineralherb.com  entered  into a Manufacturing Agreement, dated June 9,
2000, with Ives Formulation Co., of San Diego, California. Ives Formulation is a
wholly-owned subsidiary of Ives Health Company, Inc., a public company traded on
the Bulletin Board under the symbol "IVEH". Ives Formulation has been a contract
manufacturer of vitamin, mineral, nutritional supplement, and alternative health
products  for various marketing organizations. In addition to a line of standard
products,  Ives  Formulation  is able to manufacture custom blended products for
customers,  and to supply privately labeled products for WebNutri's customers at
a  minimal added cost. Vitamineralherb.com has just begun developing its vitamin
marketing  and  distributorship  business.


     Implementation  of  Business  Plan:  Milestones

     WebNutri's  business  plan  is to  determine  the  feasibility  of  selling
Vitamineralherb.com products to targeted markets. Should WebNutri determine that
its  business  plan is  feasible,  it intends to employ  salespeople  to call on
medical  professionals,  alternative health professionals,  martial arts studios
and  instructors,   sports  and  fitness  trainers,  other  health  and  fitness
professionals, school and other fund raising programs and other similar types of
customers  to  interest  these   professionals   in  selling  to  their  clients
high-quality,  low-cost vitamins,  minerals,  nutritional supplements, and other
health and fitness  products.  These  professionals  would sell the  products to
their clients via the  Internet.  WebNutri  will achieve  implementation  of its
business plan by meeting the following milestones:

     -    MILESTONE  1-MARKET  SURVEY.  In order to determine the feasibility of
          its business  plan,  WebNutri  must conduct  research into the various
          potential  target markets.  The market  analysis  research will likely
          consist of a telephone survey to 100-200 potential  clients,  focusing
          on three or four of the core target  markets,  such as  chiropractors,
          health clubs, and alternative medicine practitioners. The survey would
          likely contain questions which would determine the marketing  approach
          and  acceptability  of  specific  products.   The  survey  would  take
          approximately  four to six weeks.  The cost of the survey is estimated
          to range from $10,000-$13,500,  which would be paid for in part out of
          the proceeds of this offering.

     -    MILESTONE  2:-HIRE  SALESPEOPLE.  Should  WebNutri  determine that the
          exploitation  of the license is feasible,  it will then have to engage
          salespeople to market the products.  WebNutri expects that it may hire
          two salespeople during its first year of operation. The hiring process
          would  include  running  advertisements  in the  local  newspaper  and
          conducting  interviews.  It is anticipated that hiring the salespeople
          may take four to eight weeks. The cost of hiring the salespeople,  not
          including compensation, is estimated at $20,000.

     -    MILESTONE  3:  ESTABLISH  AN  OFFICE.  WebNutri  would  then  have  to
          establish an office or offices for the sales force in the  appropriate
          market or markets.  This would  include an office,  equipment  such as
          computers and telephones, and sample inventory for the salespeople. It
          is  anticipated  that it may take  eight  to  twelve  weeks to  locate
          acceptable office space and select and purchase equipment. The expense
          of office rental,  equipment and inventory  samples is estimated to be
          $45,000 per year.

     -    MILESTONE 4: DEVELOPMENT OF ADVERTISING CAMPAIGN.  The next step would
          be to develop an advertising campaign,  including  establishing a list
          of  prospects  based on  potential  clients  identified  in the market
          survey, and designing and printing sales materials.  It is anticipated
          that it would  take  approximately  six to ten  weeks to  develop  the
          advertising  campaign,  although,  depending  on the  availability  of
          resources,  WebNutri will attempt to develop its advertising  campaign
          concurrently with  establishing an office.  The cost of developing the
          campaign is estimated at approximately $12,000 per year.

     -    MILESTONE  5:  IMPLEMENTATION  OF  ADVERTISING  CAMPAIGN/SALES  CALLS.
          Implementation  of the  advertising  campaign would begin with mailing
          the sales materials to the identified list of prospects. Approximately
          two to four weeks  thereafter,  the salespeople  would begin telephone
          follow  ups  and  scheduling  of  sales  calls.  Although  it  will be
          necessary to make sales calls  throughout the life of the company,  it
          is   estimated   that  the  first  round  of  sales  calls  will  take
          approximately  eight to twelve weeks to  complete.  The cost of salary
          and expenses for two salespeople is estimated at $248,000 per year.

     -    MILESTONE 6: ACHIEVE REVENUES. It is difficult to quantify how long it
          will take to  convert a sales  call into  actual  sales and  revenues.
          WebNutri will not begin receiving orders until its sales force is able
          to convince potential clients to begin offering such products to their
          customers,  or to convert from an existing  supplier.  WebNutri  hopes
          that clients would begin placing  orders within weeks of a sales call,
          but it may  take  several  months  before  people  begin  to  purchase
          products.  Moreover,  customers may not be willing to pay for products
          at the time they  order,  and may insist on buying on  account,  which
          would  delay  receipt  of  revenues  another  month  or two.  Assuming
          WebNutri has received all  necessary  approvals to begin raising funds
          by March 1, 2001, and assuming an offering period of approximately one
          month, in a best case scenario WebNutri may receive its first revenues
          as early as September 1, 2001.  However,  a more realistic estimate of
          first revenues would be April 1, 2002 or later.


                                        7

     As   discussed   more   fully   in   the   Management's    Discussion   and
Analysis-Liquidity  and Capital Resources section,  the expenses of implementing
WebNutri's  business plan will likely exceed the funds raised by this  offering,
and WebNutri  will have to obtain  additional  financing  through an offering or
through capital contributions by current shareholders. No commitments to provide
additional  funds have been made by  management  or  shareholders.  Accordingly,
there can be no assurance that any  additional  funds will be available on terms
acceptable to WebNutri or at all.


     Industry  Background

     Growth  of the Internet and electronic commerce. The Internet has become an
increasingly  significant  medium  for  communication, information and commerce.
According to NUA Internet Surveys, as of February 2000, there were approximately
275.5 million Internet users worldwide. At the IDC Internet Executive Forum held
on  September  28-29, 1999, IDC stated that in 1999 US $109 billion in purchases
were impacted by the Internet. IDC's vice president, Sean Kaldor, indicated that
figure is expected to increase more than ten-fold over the next five years to US
$1.3  trillion  in  2003,  with  $842  million  completed directly over the Web.
WebNutri  believes  that this dramatic growth presents significant opportunities
for  online  retailers.

     The  vitamin, supplement, mineral and alternative health product market. In
recent  years,  a  growing  awareness  of  vitamins,  herbs,  and  other dietary
supplements  by  the general public has created a whole new segment in the field
of  medicine  and  health  care  products.  According to Jupiter Communications,
online  sales  of  such  products are expected to be US $434 million in the year
2003,  up  from  $1  million in 1998. WebNutri believes that several factors are
driving  this growth, including a rapidly growing segment of the population that
is  concerned  with aging and disease, a growing interest in preventative health
care,  favorable  consumer  attitudes  toward  alternative health products and a
favorable regulatory statute, the Dietary Supplement Health and Education Act of
1994.


     Competition

     The  electronic  commerce  industry  is new, rapidly evolving and intensely
competitive,  and  WebNutri  expects  competition  to  intensify  in the future.
Barriers  to  entry are minimal and current and new competitors can launch sites
at  a  relatively  low  cost.  In addition, the vitamin, supplement, mineral and
alternative  health  product  market  is very competitive and highly fragmented,
with  no  clear  dominant leader and increasing public and commercial attention.

     WebNutri's  competitors  can  be  divided  into  several  groups including:

     -    traditional  vitamins,  supplements,  minerals and alternative  health
          products retailers;

     -    the  online  retail  initiatives  of  several  traditional   vitamins,
          supplements, minerals and alternative health products retailers;

     -    online retailers of pharmaceutical and other  health-related  products
          that also carry vitamins, supplements, minerals and alternative health
          products;

     -    independent  online retailers  specializing in vitamins,  supplements,
          minerals and alternative health products;

     -    mail-order and catalog  retailers of vitamins,  supplements,  minerals
          and alternative health products,  some of which have already developed
          online retail outlets; and

     -    direct sales organizations, retail drugstore chains, health food store
          merchants,  mass market  retail  chains and various  manufacturers  of
          alternative health products.

     Many of WebNutri's  potential  competitors have longer operating histories,
larger  customer or user bases,  greater  brand  recognition  and  significantly
greater financial, marketing and other resources than WebNutri has. In addition,
an online retailer may be acquired by, receive  investments  from, or enter into
other commercial relationships with, larger,  well-established and well-financed
companies  as use of the  Internet  and  other  electronic  services  increases.
Competitors  have and may  continue  to adopt  aggressive  pricing or  inventory
availability  policies and devote  substantially  more  resources to website and
systems  development  than WebNutri does.  Increased  competition  may result in
reduced operating margins and loss of market share.


                                        8

     WebNutri believes that the principal competitive factors in its market are:

     -    ability to attract and retain customers;

     -    breadth of product selection;

     -    product pricing;

     -    ability to customize products and labeling;

     -    quality and responsiveness of customer service.

     WebNutri  believes that it can compete favorably on these factors. However,
WebNutri  will  have  no  control  over  how  successful  its competitors are in
addressing these factors. In addition, with little difficulty, WebNutri's online
competitors  can  duplicate  many  of  the  products  or services offered on the
Vitamineralherb.com  site.

     WebNutri  believes  that  traditional  retailers  of vitamins, supplements,
minerals  and  other  alternative  health  products  face  several challenges in
succeeding:

     -    Lack of convenience and personalized  service.  Traditional  retailers
          have limited store hours and locations. Traditional retailers are also
          unable to provide  consumers  with  product  advice  tailored to their
          particular situation.

     -    Limited  product  assortment.  The capital  and real estate  intensive
          nature of store-based  retailers limit the product  selection that can
          be economically offered in each store location.

     -    Lack of Customer Loyalty.  Although the larger  traditional  retailers
          often  attract  customers,  many of these  customers are only one-time
          users.  People are often  attractive to the name brands,  but find the
          products  too  expensive.  It is  understood  that  these are  quality
          products  and have value,  but the  multilevel  structure of marketing
          often employed by large retailers mandate high prices.

     As  a  result  of  the  foregoing  limitations,  WebNutri believes there is
significant  unmet  demand  for an alternative shopping channel that can provide
consumers  of  vitamins,  supplements,  minerals  and  other  alternative health
products  with  a  broad array of products and a convenient and private shopping
experience.

     WebNutri  hopes  to  attract and retain consumers through the following key
attributes  of  its  business:

     -    Broad Expandable Product  Assortment.  WebNutri's product selection is
          substantially larger than that offered by store-based retailers.

     -    Low  Product  Prices.  Product  prices  can be kept low due to  volume
          purchases through WebNutri's affiliation with  Vitamineralherb.com and
          other licensees.

     -    Product  prices will also be lower due to  WebNutri's  lack of need of
          inventory  and  warehouse  space.  All  products are shipped from Ives
          Formulation Company's inventory.

     -    Accessibility  to Customized  Products.  At minimal  cost,  health and
          fitness practitioners may offer their customers customized products.

     -    Access to Personalized  PrograMr.  Health or fitness  professional can
          tailor vitamin and dietary supplement regimes to their clients.


     Regulatory  Environment

     The  manufacturing,   processing,   formulating,  packaging,  labeling  and
advertising  of the products  WebNutri sells may be subject to regulation by one
or more U.S. federal agencies,  including the Food and Drug Administration,  the
Federal Trade  Commission,  the United States  Department of Agriculture and the
Environmental  Protection  Agency.  These  activities  also may be  regulated by
various  agencies  of the states,  localities  and  foreign  countries  in which
consumers reside.

     The Food and Drug Administration, in particular, regulates the formulation,
manufacture,  labeling and distribution of foods, including dietary supplements,
cosmetics and over-the-  counter or homeopathic  drugs.  Under the Federal Food,
Drug,  and  Cosmetic  Act,  the  Food  and  Drug  Administration  may  undertake
enforcement   actions  against   companies   marketing   unapproved   drugs,  or
"adulterated" or "misbranded"  products.  The remedies available to the Food and
Drug Administration  include:  criminal  prosecution;  an injunction to stop the
sale of a  company's  products;  seizure of  products;  adverse  publicity;  and
"voluntary" recalls and labeling changes.


                                        9

     Food and Drug Administration regulations require that certain informational
labeling  be  presented  in  a  prescribed  manner  on all foods, drugs, dietary
supplements  and  cosmetics.  Specifically,  the  Food,  Drug,  and Cosmetic Act
requires  that  food, including dietary supplements, drugs and cosmetics, not be
"misbranded."  A product may be deemed an unapproved drug and "misbranded" if it
bears  improper  claims  or improper labeling.  The Food and Drug Administration
has  indicated  that  promotional statements made about dietary supplements on a
company's  website may constitute "labeling" for purposes of compliance with the
provisions  of  the Food, Drug, and Cosmetic Act.  A manufacturer or distributor
of  dietary  supplements  must  notify  the Food and Drug Administration when it
markets  a  product  with  labeling claims that the product has an effect on the
structure  or  function  of  the  body.  Noncompliance  with the Food, Drug, and
Cosmetic Act, and recently enacted amendments to that Act discussed below, could
result  in  enforcement  action  by  the  Food  and  Drug  Administration.

     The Food,  Drug,  and  Cosmetic  Act has been  amended  several  times with
respect to dietary  supplements,  most  recently by the  Nutrition  Labeling and
Education  Act of 1990 and the Dietary  Supplement  Health and  Education Act of
1994.  The Dietary  Supplement  Health and Education Act created a new statutory
framework   governing  the  definition,   regulation  and  labeling  of  dietary
supplements.  With  respect to  definition,  the Dietary  Supplement  Health and
Education  Act  created  a new  class  of  dietary  supplements,  consisting  of
vitamins,  minerals,  herbs,  amino acids and other dietary substances for human
use to supplement the diet, as well as  concentrates,  metabolites,  extracts or
combinations  of  such  dietary  ingredients.   Generally,   under  the  Dietary
Supplement Health and Education Act, dietary ingredients that were on the market
before  October  15,  1994 may be sold  without  Food  and  Drug  Administration
pre-approval  and  without  notifying  the  Food  and  Drug  Administration.  In
contrast,  a new dietary ingredient,  i.e., one not on the market before October
15,  1994,  requires  proof that it has been used as an article of food  without
being  chemically  altered or evidence of a history of use or other  evidence of
safety  establishing that it is reasonably  expected to be safe.  Retailers,  in
addition to dietary supplement manufacturers,  are responsible for ensuring that
the products they market for sale comply with these  regulations.  Noncompliance
could  result  in  enforcement  action by the Food and Drug  Administration,  an
injunction  prohibiting  the sale of  products  deemed to be  noncompliant,  the
seizure of such products and criminal prosecution.

     The Food and Drug  Administration  has indicated  that claims or statements
made on a company's website about dietary supplements may constitute  "labeling"
and thus be  subject to  regulation  by the Food and Drug  Administration.  With
respect to labeling, the Dietary Supplement Health and Education Act amends, for
dietary supplements,  the Nutrition Labeling and Education Act by providing that
"statements  of nutritional  support,"  also referred to as  "structure/function
claims,"  may be used in  dietary  supplement  labeling  without  Food  and Drug
Administration  pre-approval,  provided  certain  requirements  are  met.  These
statements may describe how particular dietary  ingredients affect the structure
or  function  of the  body,  or the  mechanism  of  action  by  which a  dietary
ingredient  may affect  body  structure  or  function,  but may not state a drug
claim, i.e., a claim that a dietary supplement will diagnose,  mitigate,  treat,
cure or prevent a disease. A company making a "statement of nutritional support"
must possess  substantiating  evidence for the statement,  disclose on the label
that the Food and Drug  Administration  has not reviewed the  statement and that
the product is not  intended  for use for a disease and notify the Food and Drug
Administration  of the  statement  within 30 days after its  initial  use. It is
possible that the statements  presented in connection with product  descriptions
on WebNutri'  site may be determined by the Food and Drug  Administration  to be
drug  claims  rather than  acceptable  statements  of  nutritional  support.  In
addition, some of WebNutri' suppliers may incorporate  objectionable  statements
directly in their product names or on their products'  labels, or otherwise fail
to comply with applicable manufacturing,  labeling and registration requirements
for over-the-counter or homeopathic drugs or dietary  supplements.  As a result,
Vitamineralherb.com may have to remove objectionable statements or products from
its site or modify these  statements,  or product  names or labels,  in order to
comply  with  Food and  Drug  Administration  regulations.  Such  changes  could
interfere  with  WebNutri'  marketing  of  products  and could cause us to incur
significant additional expenses.

     In addition,  the Dietary  Supplement  Health and  Education Act allows the
dissemination of "third party literature" in connection with the sale of dietary
supplements  to  consumers  at  retail  if  the   publication   meets  statutory
requirements.  Under the Dietary  Supplement  Health and Education  Act,  "third
party  literature" may be distributed if, among other things, it is not false or
misleading,  no  particular  manufacturer  or brand  of  dietary  supplement  is
promoted,  a balanced view of available  scientific  information  on the subject
matter is presented and there is physical separation from dietary supplements in
stores.  The extent to which this  provision may be used by online  retailers is
not yet clear,  and WebNutri  cannot  assure you that all pieces of "third party
literature"  that may be disseminated  in connection with the products  WebNutri
offers  for  sale  will  be  determined  to be  lawful  by  the  Food  and  Drug
Administration. Any such failure could render the involved product an unapproved
drug or a "misbranded" product,  potentially subjecting us to enforcement action
by the Food and Drug  Administration,  and  could  require  the  removal  of the
noncompliant literature from  Vitamineralherb.com's  website or the modification
of WebNutri' selling methods,  interfering with WebNutri continued  marketing of
that product and causing us to incur significant additional expenses.  Given the
fact that the Dietary  Supplement Health and Education Act was enacted only five
years ago, the Food and Drug Administration's  regulatory policy and enforcement
positions  on  certain  aspects  of the new law are  still  evolving.  Moreover,
ongoing and future litigation between dietary supplement  companies and the Food
and Drug Administration will likely further refine the legal  interpretations of
the Dietary  Supplement  Health and Education  Act. As a result,  the regulatory
status of certain types of dietary  supplement  products,  as well as the nature
and extent of permissible claims will remain unclear for the foreseeable future.
Two areas in particular  that pose potential  regulatory  risk are the limits on
claims implying some benefit or relationship with a disease or related condition
and the  application  of the physical  separation  requirement  for "third party
literature" as applied to Internet sales.


                                       10

     In addition to the regulatory scheme under the Food, Drug and Cosmetic Act,
the  advertising  and  promotion of dietary supplements, foods, over-the-counter
drugs and cosmetics is subject to scrutiny by the Federal Trade Commission.  The
Federal  Trade  Commission  Act  prohibits  "unfair or deceptive" advertising or
marketing  practices, and the Federal Trade Commission has pursued numerous food
and  dietary supplement manufacturers and retailers for deceptive advertising or
failure to substantiate promotional claims, including, in many instances, claims
made  via  the  Internet.  The  Federal  Trade  Commission has the power to seek
administrative  or  judicial  relief  prohibiting  a  wide variety of claims, to
enjoin future advertising, to seek redress or restitution payments and to seek a
consent  order and seek monetary penalties for the violation of a consent order.
In  general, existing laws and regulations apply fully to transactions and other
activity  on  the  Internet.  The  Federal Trade Commission is in the process of
reviewing its policies regarding the applicability of its rules and its consumer
protection guides to the Internet and other electronic media.  The Federal Trade
Commission  has  already undertaken a new monitoring and enforcement initiative,
"Operation  Cure-All,"  targeting allegedly bogus health claims for products and
treatments  offered  for  sale  on  the  Internet.  Many states impose their own
labeling  or  safety  requirements  that  differ from or add to existing federal
requirements.

     WebNutri  cannot  predict  the nature of any future U.S. laws, regulations,
interpretations  or  applications,  nor  can it determine what effect additional
governmental  regulations  or  administrative  orders,  when and if promulgated,
would  have  on  its business in the future.  Although the regulation of dietary
supplements  is less restrictive than that of drugs and food additives, WebNutri
cannot  assure  you that the current statutory scheme and regulations applicable
to  dietary  supplements will remain less restrictive.  Further, WebNutri cannot
assure  you  that,  under  existing  laws  and regulations, or if more stringent
statutes  are  enacted,  regulations are promulgated or enforcement policies are
adopted,  it  is  or  will be in compliance with these existing or new statutes,
regulations  or  enforcement  policies  without  incurring  material expenses or
adjusting  its  business strategy.  Any laws, regulations, enforcement policies,
interpretations  or  applications applicable to WebNutri' business could require
the  reformulation  of  certain  products  to  meet new standards, the recall or
discontinuance  of  certain  products  not  capable of reformulation, additional
record  keeping,  expanded  documentation of the properties of certain products,
expanded  or  different  labeling  or  scientific  substantiation.


     Regulation  of  the  Internet

     In  general,  existing laws and regulations apply to transactions and other
activity  on  the Internet; however, the precise applicability of these laws and
regulations  to  the Internet is sometimes uncertain.  The vast majority of such
laws  were  adopted prior to the advent of the Internet and, as a result, do not
contemplate or address the unique issues of the Internet or electronic commerce.
Nevertheless,  numerous  federal  and  state  government  agencies  have already
demonstrated significant activity in promoting consumer protection and enforcing
other  regulatory and disclosure statutes on the Internet.  Additionally, due to
the  increasing  use of the Internet as a medium for commerce and communication,
it  is possible that new laws and regulations may be enacted with respect to the
Internet  and  electronic commerce covering issues such as user privacy, freedom
of  expression,  advertising,  pricing,  content  and  quality  of  products and
services,  taxation, intellectual property rights and information security.  The
adoption  of such laws or regulations and the applicability of existing laws and
regulations  to the Internet may impair the growth of Internet use and result in
a  decline  in  WebNutri's  sales.

     A  number of legislative proposals have been made at the federal, state and
local  level,  and by foreign governments, that would impose additional taxes on
the  sale of goods and services over the Internet, and certain states have taken
measures  to tax Internet-related activities.  Although Congress recently placed
a  three-year  moratorium  on new state and local taxes on Internet access or on
discriminatory  taxes  on electronic commerce, existing state or local laws were
expressly  excepted  from  this  moratorium.  Further,  once  this moratorium is
lifted,  some  type  of  federal and/or state taxes may be imposed upon Internet
commerce.  Such  legislation  or  other attempts at regulating commerce over the
Internet may substantially impair the growth of commerce on the Internet and, as
a  result,  adversely  affect  WebNutri' opportunity to derive financial benefit
from  such  activities.


     Employees

     WebNutri is a  development  stage  company and  currently has no employees.
WebNutri is  currently  managed by Peter Finck,  its sole officer and  director.
WebNutri  looks  to Mr.  Finck  for  his  entrepreneurial  skills  and  talents.
Management plans to use consultants,  attorneys and accountants as necessary and
does not plan to engage any full-time employees in the near future. WebNutri may
hire  marketing  employees  based on the  projected  size of the  market and the
compensation  necessary to retain  qualified sales  employees.  A portion of any
employee  compensation  likely  would  include  the  right to  acquire  stock in
WebNutri,  which  would  dilute the  ownership  interest  of holders of existing
shares of its common stock.


                                       11

     Available  Information  and  Reports  to  Securities  Holders

     WebNutri  has  filed  with  the  Securities   and  Exchange   Commission  a
registration  statement on Form SB-2 with respect to the common stock offered by
this prospectus.  This prospectus,  which constitutes a part of the registration
statement, does not contain all of the information set forth in the registration
statement  or the  exhibits  and  schedules  which are part of the  registration
statement.  For further  information  with  respect to  WebNutri  and its common
stock,  see the registration  statement and the exhibits and schedules  thereto.
Any document  WebNutri files may be read and copied at the  Commission's  Public
Reference Room located at 450 Fifth Street N.W.,  Washington D.C. 20549, and the
public reference rooms in New York, New York, and Chicago, Illinois. Please call
the  Commission  at  1-800-SEC-0330  for  further  information  about the public
reference  rooMr.  WebNutri's  filings with the Commission are also available to
the public from the Commission's website at http://www.sec.gov.

     Upon  completion  of  this  offering,  WebNutri  will become subject to the
information  and  periodic reporting requirements of the Securities Exchange Act
and,  accordingly,  will  file  periodic  reports,  proxy  statements  and other
information  with  the  Commission.  Such periodic reports, proxy statements and
other  information  will  be  available  for  inspection  and  copying  at  the
Commission's  public reference rooms, and the website of the Commission referred
to  above.


            MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION

     The following discussion and analysis of WebNutri's financial condition and
results  of  operations  should  be  read  in  conjunction  with  the  Financial
Statements  and accompanying notes and the other financial information appearing
elsewhere  in  this  Prospectus.

     This prospectus contains forward-looking  statements, the accuracy of which
involve  risks  and  uncertainties.  Words  such as  "anticipates,"  "believes,"
"plans,"  "expects,"  "future,"  "intends" and similar  expressions  are used to
identify   forward-looking    statements.    This   prospectus   also   contains
forward-looking statements attributed to certain third parties relating to their
estimates  regarding the  potential  markets for  Vitamineralherb.com  products.
Prospective  investors should not place undue reliance on these  forward-looking
statements,  which  apply  only as of the  date of this  prospectus.  WebNutri's
actual  results  could  differ   materially  from  those  anticipated  in  these
forward-looking  statements  for many  reasons,  including  the  risks  faced by
WebNutri  described in "Risk  Factors" and  elsewhere  in this  prospectus.  The
following  discussion and analysis should be read in conjunction with WebNutri's
Financial Statements and Notes thereto and other financial  information included
elsewhere in this prospectus.


     Results  of  Operations

     During the period  from  December  15,  2000  through  December  31,  2000,
WebNutri  has engaged in no  significant  operations  other than  organizational
activities,   acquisition  of  the  rights  to  market  Vitamineralherb.com  and
preparation for registration of its securities under the Securities Act of 1933,
as amended. No revenues were received by WebNutri during this period.

     For  the  current  fiscal  year, WebNutri anticipates incurring a loss as a
result  of  organizational expenses, expenses associated with registration under
the  Securities  Act  of 1933, and expenses associated with setting up a company
structure  to  begin  implementing  its business plan. WebNutri anticipates that
until  these  procedures  are  completed, it will not generate revenues, and may
continue  to operate at a loss thereafter, depending upon the performance of the
business.

     WebNutri's  business  plan is to determine the feasibility of marketing the
Vitamineralherb.com  products  in various markets, and, if the products prove to
be  in  demand,  begin  marketing  and  selling  Vitamineralherb.com  products.


     Liquidity  and  Capital  Resources

     WebNutri  remains  in the  development  stage  and,  since  inception,  has
experienced  no  significant   change  in  liquidity  or  capital  resources  or
shareholders' equity. Consequently,  WebNutri's balance sheet as of December 31,
2000,  reflects  total  assets of $0, in the form of a license  and  capitalized
organizational  costs.  Organizational  expenses of $16,000 were paid for by the
sole shareholder and expensed to operations.


                                       12

     WebNutri's  business  plan  is to  determine  the  feasibility  of  selling
Vitamineralherb.com products to targeted markets. Should WebNutri determine that
its  business  plan is  feasible,  it intends to employ  salespeople  to call on
medical  professionals,  alternative health professionals,  martial arts studios
and  instructors,   sports  and  fitness  trainers,  other  health  and  fitness
professionals, school and other fund raising programs and other similar types of
customers  to  interest  these   professionals   in  selling  to  their  clients
high-quality,  low-cost vitamins,  minerals,  nutritional supplements, and other
health and fitness  products.  These  professionals  would sell the  products to
their clients via the Internet.

     In order to determine the feasibility of its business plan, WebNutri plans,
during  the  next  six  to twelve months, to conduct research into these various
potential target markets. Should WebNutri determine that the exploitation of the
license  is  feasible,  it will engage salespeople to market the products. Based
primarily  on  discussions  with the licensor, WebNutri believes that during its
first  operational  quarter,  it  will  need a capital infusion of approximately
$70,000  to  achieve  a  sustainable sales level where ongoing operations can be
funded  out  of  revenues.  This  capital infusion is intended to cover costs of
advertising,  hiring and paying two salespeople, and administrative expenses. In
addition,  WebNutri  will need approximately $260,000 in the event it determines
that its market will not pay in advance and it will have to extend credit. These
expenses  will  exceed the funds raised by this offering, and WebNutri will have
to  obtain  additional financing through an offering or capital contributions by
current  shareholders.

     WebNutri is conducting this offering,  in part, because it believes that an
early   registration  of  its  equity  securities  will  minimize  some  of  the
impediments to capital  formation that otherwise exist. By having a registration
statement in place, WebNutri believes it will be in a better position, either to
conduct a future  public  offering of its  securities  or to undertake a private
placement  with  registration  rights,  than  if it  were a  completely  private
company.  Registering  its shares will help  minimize  the  liquidity  discounts
WebNutri may otherwise have to take in a future private  placement of its equity
securities,  because  investors  will have a high degree of confidence  that the
Rule 144(c)(1) public  information  requirement will be satisfied,  and a public
market will exist to effect Rule 144(g) broker  transactions.  WebNutri believes
that the cost of registering  its  securities,  and  undertaking the affirmative
disclosure  obligations  that  such a  registration  entails,  will be more than
offset by avoiding deep liquidity  discounts in future sales of  securities.  No
specific private investors have been identified,  but WebNutri's  management has
general knowledge of an investor class interested in investing in companies that
can demonstrate a clear path to an early liquidity event.

     No  commitments to provide additional funds have been made by management or
shareholders.  Accordingly,  there can be no assurance that any additional funds
will be available on terms acceptable to WebNutri or at all. WebNutri expects to
begin  earning  revenues  shortly  after  a  sales  force  is  in  place.

     In  addition,  WebNutri  may engage in a combination with another business.
WebNutri  cannot predict the extent to which its liquidity and capital resources
will  be  diminished  prior  to  the  consummation  of a business combination or
whether its capital will be further depleted by the operating losses (if any) of
the  business  entity  with  which WebNutri may eventually combine. WebNutri has
engaged  in  discussions concerning potential business combinations, but has not
entered  into  any  agreement  for  such  a  combination.

     WebNutri  will need additional capital to carry out its business plan or to
engage  in  a  business  combination. No commitments to provide additional funds
have been made by management or other shareholders. Accordingly, there can be no
assurance  that  any  additional  funds will be available on terms acceptable to
WebNutri  or  at  all.  WebNutri  has  no  commitments for capital expenditures.


                             DESCRIPTION OF PROPERTY

     WebNutri currently maintains limited office space, occupied by Peter Finck,
for  which it pays no rent. Its address 5621 Eagle Harbour Road, West Vancouver,
British  Columbia,  Canada  V7W  1P4  and  its  phone  number is (604) 922-4068.
WebNutri does not believe that it will need to obtain additional office space at
any  time  in  the  foreseeable  future  until  its  business plan is more fully
implemented.

                 CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS

     No  director,  executive  officer  or nominee for election as a director of
WebNutri,  and no owner of five percent or more of WebNutri's outstanding shares
or  any  member  of  their  immediate  family  has  entered into or proposed any
transaction  in  which  the  amount  involved  exceeds  $60,000.


                                       13

            MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS

     No  established  public  trading  market  exists for WebNutri's securities.
WebNutri  has  no  common  equity  subject  to  outstanding  purchase options or
warrants.  WebNutri  has no securities convertible into its common equity. There
is no common equity that could be sold pursuant to Rule 144 under the Securities
Act or that WebNutri has agreed to register under the Securities Act for sale by
shareholders. Except for this offering, there is no common equity that is being,
or  has  been  publicly  proposed  to  be,  publicly  offered  by  WebNutri.

     As  of  December  31,  2000,  there  were  5,100,000 shares of common stock
outstanding,  held  by  1  shareholder  of  record.  Upon  effectiveness  of the
registration  statement  that  includes  this  prospectus,  all  of  WebNutri's
outstanding  shares  will  be  eligible  for  sale.

     To  date  WebNutri  has not paid any dividends on its common stock and does
not  expect  to  declare  or  pay  any  dividends  on  its  common  stock in the
foreseeable  future. Payment of any dividends will depend upon WebNutri's future
earnings,  if any, its financial condition, and other factors as deemed relevant
by  the  Board  of  Directors.


                             EXECUTIVE COMPENSATION

     No  officer  or  director  has  received  any  remuneration  from WebNutri.
Although  there  is  no  current plan in existence, it is possible that WebNutri
will  adopt  a  plan to pay or accrue compensation to its officers and directors
for services related to the implementation of WebNutri's business plan. WebNutri
has  no stock option, retirement, incentive, defined benefit, actuarial, pension
or  profit-sharing  programs  for  the  benefit  of directors, officers or other
employees, but the Board of Directors may recommend adoption of one or more such
programs in the future. WebNutri has no employment contract or compensatory plan
or  arrangement  with  any executive officer of WebNutri. The director currently
does not receive any cash compensation from WebNutri for his service as a member
of  the  board  of  directors.  There  is  no  compensation  committee,  and  no
compensation  policies have been adopted. See "Certain Relationships and Related
Transactions."


                CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON
                       ACCOUNTING AND FINANCIAL DISCLOSURE

None.


                                      14

                              FINANCIAL STATEMENTS

WebNutri.com  Inc.
(A  Development  Stage  Company)

                                                      Index

Independent  Auditor's  Report                         F-1

Balance  Sheet                                         F-2

Statement  of  Operations                              F-3

Statement  of  Cash  Flows                             F-4

Statement  of  Stockholders'  Equity                   F-5

Notes  to  the  Financial  Statements                  F-6



                               [GRAPHIC  OMITED]

Manning Elliott                        |    11th floor, 1050 West Pender Street,
                                       |    Vancouver, BC, Candada  V6E 3S7
                                       |
Chartered Accountants                  |    Tel: 604.714.3600  Fax: 604.714.3669
                                       |    Web:  manningelliott.com


                          Independent Auditor's Report
                          ----------------------------


To  the  Board  of  Directors
WebNutri.com  Inc.
(A  Development  Stage  Company)


We  have  audited  the  accompanying  balance  sheet  of  WebNutri.com  Inc.  (A
Development  Stage Company as of December 31, 2000 and the related statements of
operations, stockholders' equity and cash flows for the period from December 15,
2000  (Date  of  Inception) to December 31, 2000. These financial statements are
the responsibility of the Company's management. Our responsibility is to express
an  opinion  on  these  financial  statements  based  on  our  audit.

We  conducted  our  audit  in  accordance  with U.S. generally accepted auditing
standards.  Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material
misstatement.  An audit includes examining, on a test basis, evidence supporting
the  amounts and disclosures in the financial statements. An audit also includes
assessing  the  accounting  principles  used  and  significant estimates made by
management,  as well as evaluating the overall financial statement presentation.
We  believe  that  our  audit  provides  a  reasonable  basis  for  our opinion.

In  our  opinion, the aforementioned financial statements present fairly, in all
material  respects,  the  financial position of WebNutri.com Inc. (A Development
Stage  Company),  as of December 31, 2000, and the results of its operations and
its  cash  flows  for  the  period from December 15, 2000 (Date of Inception) to
December  31,  2000,  in  conformity  with  U.S.  generally  accepted accounting
principles.

The  accompanying  financial  statements have been prepared assuming the Company
will  continue  as  a  going  concern.  As  discussed in Note 1 to the financial
statements,  the  Company  has  not  generated  any  revenues  or  conducted any
operations  since  inception.  These  factors  raise substantial doubt about the
Company's  ability  to continue as a going concern. Management's plans in regard
to  these  matters are also discussed in Note 1. The financial statements do not
include  any adjustments that might result from the outcome of this uncertainty.


                                                           CHARTERED ACCOUNTANTS

Vancouver,  Canada
January  2,  2001


                                      F-1

WebNutri.com  Inc.
(A  Development  Stage  Company)
Balance  Sheet


                                                     December  31,
                                                         2000
                                                           $


                               Assets
License (Note 3)                                                -
==================================================================

                 Liabilities and Stockholders' Equity

Current Liabilities
 Accrued liabilities                                        2,000
- ------------------------------------------------------------------
Stockholders' Equity
Common Stock, 100,000,000 common shares authorized
with a par value of $0.0001; 5,100,000 common shares
issued and outstanding                                        510

Additional Paid in Capital                                 50,490
- ------------------------------------------------------------------
                                                           51,000
- ------------------------------------------------------------------
                                                           53,000
- ------------------------------------------------------------------

Preferred Stock, 20,000,000 preferred shares authorized
with a par value of $0.0001; none issued                        -
Deficit Accumulated During the Development Stage          (53,000)
- ------------------------------------------------------------------
                                                          (53,000)
- ------------------------------------------------------------------

                                                                -
==================================================================


Contingent Liability (Note 1)
Commitment (Note 3)


                                      F-2
    (The accomanying notes are an integral part of the financial statements)

WebNutri.com  Inc.
(A  Development  Stage  Company)
Statement  of  Operations


                                  From December 15, 2000
                                    (Date of Inception)
                                   to December 31, 2000
                                             $

Revenue                                         -
- --------------------------------------------------------
Expenses

   Audit                                    2,000
   Legal and organizational                16,000
   License written-off                     35,000
- --------------------------------------------------------
                                           53,000
- --------------------------------------------------------
Net Loss                                  (53,000)
========================================================
Loss per share                              (0.01)
========================================================
Weighted Average Shares Outstanding     5,100,000
========================================================


                                      F-3
    (The accomanying notes are an integral part of the financial statements)

WebNutri.com  Inc.
(A  Development  Stage  Company)
Statement  of  Cash  Flows
Statement  of  Cash  Flows
                                                   From December 15, 2000
                                                    (Date of Inception)
                                                    to December 31, 2000
                                                              $

Cash Flows to Operating Activities

  Net loss                                                       (53,000)

  Non-cash items

  Legal and organizational expenses                               16,000
  License written-off                                             35,000
  Accrued liabilities                                              2,000
- -------------------------------------------------------------------------
    Net Cash Used by Operating Activities                              -
- -------------------------------------------------------------------------
Change in cash                                                         -

Cash - beginning of period                                             -
- -------------------------------------------------------------------------
Cash - end of period                                                   -
=========================================================================


Non-Cash Financing Activities

    A  total  of 1,600,000 shares were issued to the
    sole shareholder at a fair market value of $0.01
    per  share for legal and organizational expenses
    paid                                                          16,000

    A  total  of  3,500,000  shares were issued at a
    fair  market  value  of  $0.01 per share for the
    acquisition of a License (Note 3)                             35,000
- -------------------------------------------------------------------------
                                                                  51,000
=========================================================================
Supplemental Disclosures

    Interest paid                                                      -
    Income tax paid                                                    -


                                      F-4
    (The accomanying notes are an integral part of the financial statements)



WebNutri.com  Inc.
(A  Development  Stage  Company)
Statement  of  Stockholders'  Equity


                                                                                                 Deficit
                                                                                               Accumulated
                                                                           Additional          During the
                                                          Common Stock      Paid-in            Development
                                                        Shares    Amount    Capital     Total    Stage
                                                          #         $          $          $        $
                                                                                
Balance - December 15, 2000 (Date of Inception)               -         -        -        -             -

  Stock issued for legal and organizational
  expenses at a fair market value of $0.01 per
  share                                               1,600,000       160     15,840   16,000           -

  Stock issued for the acquisition of a license at
  a fair market value of $0.01 per share              3,500,000       350     34,650   35,000           -

Net loss for the period                                       -         -          -        -     (51,000)
- ----------------------------------------------------------------------------------------------------------
Balance - December 31, 2000                           5,100,000       510     50,490   51,000     (51,000)
==========================================================================================================



                                      F-5
    (The accomanying notes are an integral part of the financial statements)

WebNutri.com  Inc.
(A  Development  Stage  Company)
Notes  to  the  Financial  Statements
- -------------------------------------

1.   Development Stage Company

     WebNutri.com  Inc. herein (the "Company") was  incorporated in the State of
     Washington,  U.S.A. on December 15, 2000. The Company acquired a license to
     market and distribute  vitamins,  minerals,  nutritional  supplements,  and
     other health and fitness  products in Alabama and  Louisiana,  in which the
     grantor  of the  license  offers  these  products  for  sale  from  various
     suppliers on their Web Site.

     The Company is in the development  stage.  In a development  stage company,
     management  devotes most of its  activities  in developing a market for its
     products.  Planned principal  activities have not yet begun. The ability of
     the  Company  to emerge  from the  development  stage  with  respect to any
     planned  principal  business  activity  is  dependent  upon its  successful
     efforts to raise  additional  equity  financing  and/or  attain  profitable
     operations.  There is no  guarantee  that the Company will be able to raise
     any equity  financing  or sell any of its  products  at a profit.  There is
     substantial  doubt  regarding the Company's  ability to continue as a going
     concern.

     The Company will offer 2,500,000 shares at $0.01 per share to raise $25,000
     pursuant to an SB-2 Registration  Statement to be filed with the Securities
     and Exchange Commission.

2.   Summary of Significant Accounting Policies

     (a)  Year end

          The Company's fiscal year end is December 31.

     (b)  License

          The cost to acquire  the  License  was  capitalized.  The cost will be
          amortized on a straight-line basis over twelve months.

          The  carrying  value of the  License is  evaluated  in each  reporting
          period to determine if there were events or circumstances  which would
          indicate a possible  inability  to recover the carrying  amount.  Such
          evaluation  is based  on  various  analyses  including  assessing  the
          Company's  ability  to bring the  commercial  applications  to market,
          related profitability projections and undiscounted cash flows relating
          to each application which necessarily involves significant  management
          judgment.

     (c)  Cash and Cash Equivalents

          The Company considers all highly liquid instruments with a maturity of
          three  months  or  less  at  the  time  of  the  issuance  to be  cash
          equivalents.

     (d)  Use of Estimates

          The  preparation of financial  statements in conformity with generally
          accepted  accounting  principles requires management to make estimates
          and  assumptions  that  affect  the  reported  amounts  of assets  and
          liabilities and disclosure of contingent assets and liabilities at the
          date of the financial  statements and the reported amounts of revenues
          and expenses  during the  periods.  Actual  results  could differ from
          those estimates.

     (e)  Revenue Recognition

          The Company will receive from the Grantor of the license,  commissions
          of one-half of all the profit on all sales made through the  Grantor's
          Web Site. The commission  revenue will be recognized in the period the
          sales have occurred. The Company will report the commission revenue on
          a net basis as the  Company is acting as an Agent for the  Grantor and
          does not assume any risks or rewards of the ownership of the products.
          This  policy  is  prospective  in nature  as the  Company  has not yet
          generated any revenue.


                                      F-6


3.   License and Related Party Transaction

     The  Company's  only  asset is a  license  to  market  vitamins,  minerals,
     nutritional  supplements and other health and fitness  products through the
     Grantor's Web Site. The Company desires to market these products to medical
     practitioners,  alternative health professionals,  martial arts studios and
     instructors,   sports  and  fitness  trainers,  other  health  and  fitness
     practitioners,  school and other fund raising  programs  and other  similar
     types of  customers in Alabama and  Louisiana.  The license was acquired on
     December 15, 2000 for a term of three years. The Company must pay an annual
     fee of $500 for  maintenance  of the Grantor's  Web Site  commencing on the
     anniversary date. The Grantor of the license retains 50% of the profits.

     The Company issued  3,500,000  shares to the sole  shareholder  with a fair
     market value of $0.01 per share for a total  consideration of $35,000 which
     is the same as the transferor's cost.

     The License has been written-off to operations as at December 31, 2000, due
     to the lack of historical cash flow of Vitaminmineralherb.com.  However, it
     is the Company's  intention to determine if it is economically  feasible to
     commercially exploit a business plan.


                                      F-7

                                   Prospectus

                               [ENTER DATE, 2001]

                                WebNutri.com Inc.
                             5621 Eagle Harbour Road
                   Vancouver, British Columbia Canada V7W 1P4
                                 (604) 922-4068

                        2,500,000 Shares of Common Stock



          WebNutri.com  has not  authorized  any  dealer,  salesperson  or other
person to give you written  information  other than this  prospectus  or to make
representations  as to matters not stated in this prospectus.  You must not rely
on  unauthorized  information.  This  prospectus  is not an offer to sell  these
securities  or a  solicitation  of  your  offer  to buy  the  securities  in any
jurisdiction where that would not be permitted or legal. Neither the delivery of
this  prospectus nor any sales made hereunder  after the date of this prospectus
shall create an implication that the information contained herein or the affairs
of WebNutri.com have not changed since the date hereof.


          Until  _____________  ___,  2001  (90  days  after  the  date  of this
prospectus),  all dealers  that effect  transactions  in these  shares of common
stock may be  required  to  deliver a  prospectus.  This is in  addition  to the
dealer's  obligation to deliver a prospectus  when acting as an underwriter  and
with respect to their unsold allotments or subscriptions.


                                      15

                 PART II-INFORMATION NOT REQUIRED IN PROSPECTUS

                    INDEMNIFICATION OF DIRECTORS AND OFFICERS

     WebNutri's  Articles  of  Incorporation  provide that it must indemnify its
directors  and  officers  to  the  fullest extent permitted under Washington law
against all liabilities incurred by reason of the fact that the person is or was
a director or officer of WebNutri or a fiduciary of an employee benefit plan, or
is  or  was  serving  at  the  request  of WebNutri as a director or officer, or
fiduciary  of  an  employee  benefit  plan, of another corporation, partnership,
joint  venture,  trust,  employee  benefit  plan  or  other  enterprise.

     The effect of these  provisions  is  potentially  to  indemnify  WebNutri's
directors and officers from all costs and expenses of liability incurred by them
in connection with any action,  suit or proceeding in which they are involved by
reason of their  affiliation  with  WebNutri.  Pursuant  to  Washington  law,  a
corporation  may indemnify a director,  provided that such  indemnity  shall not
apply on account of: (a) acts or omissions of the director  finally  adjudged to
be  intentional   misconduct  or  a  knowing  violation  of  law;  (b)  unlawful
distributions;  or (c) any  transaction  with  respect  to which it was  finally
adjudged that such director personally received a benefit in money, property, or
services to which the director was not legally entitled.

     The  bylaws  of  WebNutri  provide  that it will indemnify its officers and
directors  for  costs  and  expenses  incurred in connection with the defense of
actions,  suits, or proceedings against them on account of their being or having
been  directors  or  officers  of  WebNutri,  absent  a finding of negligence or
misconduct  in office. WebNutri's Bylaws also permit it to maintain insurance on
behalf  of  its  officers, directors, employees and agents against any liability
asserted  against  and  incurred  by that person whether or not WebNutri has the
power  to  indemnify  such  person  against  liability  for  any  of those acts.


                   OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION

     The  amounts  set  forth are estimates except for the SEC registration fee:

                                                         AMOUNT TO
                                                          BE PAID
                                                         ---------
  SEC registration fee  . . . . . . . . . . . . . . . .  $       10
  Printing and engraving expenses  .. . . . . . . . . .       2,500
  Attorneys' fees and expenses  . . . . . . . . . . . .      16,000
  Accountants' fees and expenses  . . . . . . . . . . .       2,000
  Transfer agent's and registrar's fees and expenses  .         500
  Miscellaneous  .. . . . . . . . . . . . . . . . . . .         550
                                                         ----------
  Total  .. . . . . . . . . . . . . . . . . . . . . . .  $   21,560
                                                         ==========

     The  Registrant  will  bear  all  expenses  shown  above.


                     RECENT SALES OF UNREGISTERED SECURITIES

     Set  forth  below  is  information  regarding  the  issuance  and  sales of
WebNutri's  securities  without  registration since its formation. No such sales
involved  the  use  of an underwriter and no commissions were paid in connection
with  the  sale  of  any  securities.

     On  December  15, 2000, WebNutri issued 5,100,000 shares of common stock to
Michael  Kirsh in compensation for the license of Vitamineralherb.com rights and
organizational  costs.  The  issuance of the shares was exempt from registration
under Rule 506 of Regulation D, and sections 3(b) and 4(2) of the Securities Act
of  1933,  as amended, due to Michael Kirsh's status as the founder of WebNutri,
and  his  status  as an accredited investor, and the limited number of investors
(one).


                                     II-1

                                    EXHIBITS

     The  following  exhibits  are filed as part of this Registration Statement:


         EXHIBIT
         NUMBER   DESCRIPTION
         -------  -----------

             3.1    Articles of Incorporation
             3.2    Bylaws
             4.1    Specimen Stock Certificate
             4.2    Stock Subscription Agreement
             5.1    Opinion re: legality
            10.1    License Agreement
            10.2    Assignment of License Agreement
            23.1    Consent of Independent Auditors
            23.2    Consent of Counsel (see Exhibit 5.1)



                                  UNDERTAKINGS

     The  Registrant  hereby  undertakes  that  it  will:

          (1) File, during any period in which it offers or sells securities,  a
     post-effective amendment to this registration statement to:

               (i) Include any  prospectus  required by section  10(a)(3) of the
          Securities Act;

               (ii)  Reflect  in the  prospectus  any  facts  or  events  which,
          individually  or  together,  represent  a  fundamental  change  in the
          information in the registration statement; and

               (iii) Include any additional or changed  material  information on
          the plan of distribution.

          (2) For  determining  liability  under the Securities  Act, treat each
     post-effective  amendment as a new registration statement of the securities
     offered,  and the Offering of the securities of the securities at that time
     to be the initial bona fide Offering.

          (3) File a post-effective amendment to remove from registration any of
     the securities that remain unsold at the end of the Offering.

     Insofar as indemnification for liabilities arising under the Securities Act
may  be  permitted  to  directors,  officers  and  controlling  persons  of  the
Registrant  pursuant  to  the foregoing provisions, or otherwise, the Registrant
has  been  advised that in the opinion of the Securities and Exchange Commission
such indemnification is against public policy as expressed in the Securities Act
and  is,  therefore,  unenforceable.

     In  the  event  that  a  claim for indemnification against such liabilities
(other  than  the  payment  by  the Registrant of expenses incurred or paid by a
director,  officer  or  controlling  person  of the registrant in the successful
defense of any action, suit or proceeding) is asserted by such director, officer
or  controlling  person  in connection with the securities being registered, the
Registrant  will,  unless  in  the  opinion  of  its counsel the matter has been
settled  by controlling precedent, submit to a court of appropriate jurisdiction
the  question  whether  such  indemnification  by it is against public policy as
expressed  in  the Securities Act and will be governed by the final adjudication
of  such  issue.


                                     II-2

                                   SIGNATURES

     In  accordance  with  the  requirements  of the Securities Act of 1933, the
registrant certifies that it has reasonable grounds to believe that it meets all
of  the  requirements  for  filing on Form SB-2 and authorized this registration
statement  to  be  signed  on  its  behalf  by  the  undersigned, thereunto duly
authorized,  in  the City of West Vancouver, British Columbia Canada, on January
9,  2001.


                                       WEBNUTRI.COM  INC.



                                       By:  /s/
                                          --------------------------------
                                                    PETER FINCK
                                                     PRESIDENT

     In  accordance  with  the  requirements of the Securities Act of 1933, this
registration  statement  has  been  signed  by  the  following  persons  in  the
capacities  and  on  the  dates  stated.

    SIGNATURE                  TITLE                                 DATE
    ---------                  -----                                 ----

/s/              President, Secretary, Treasurer, and Director   January 9, 2001
- ----------------
PETER FINCK



                                LIST OF EXHIBITS

     The  following  exhibits  are filed as part of this Registration Statement:

         EXHIBIT
         NUMBER   DESCRIPTION
         -------  -----------

             3.1    Articles of Incorporation
             3.2    Bylaws
             4.1    Specimen Stock Certificate
             4.2    Stock Subscription Agreement
             5.1    Opinion re: legality
            10.1    License Agreement
            10.2    Assignment of License Agreement
            23.1    Consent of Independent Auditors
            23.2    Consent of Counsel (see Exhibit 5.1)


                                     II-3